Stem Cell Therapy For Stroke Patients
Source: Veristat, Inc.

A client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in patients following an ischemic stroke. The goal was to look at limb recovery time and level in patients with stroke. The effort began with identifying the best time for a product to be delivered and then expanded into full-service involvement, including project management, clinical monitoring, monitoring, safety, medical monitoring, medical and regulatory affairs.
Study Demographics
Phase II Multi-Center Efficacy Study
Primary Services Provided:
- Project Management
- Clinical Monitoring
- Medical Writing
- Regulatory Affairs
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Cell & Gene? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Veristat, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more